ENvue Medical , Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement and therapeutic technologies, today announced that it has resumed commercial shipments of PainShield®, manufactured in the United States, and has begun fulfilling open orders from Ultra Pain Products, Inc. ("UPPI"), the Company’s exclusive U.S. distribution partner for the product.

The resumption of shipments marks an important commercial and operational milestone following the transfer of NanoVibronix manufacturing operations from Israel to the United States. With U.S. production now operational, the Company is restoring commercial supply of PainShield and fulfilling existing distributor orders.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.